Archive - March 2018
AbbVie’s uterine fibroids drug aces second phase III trial
Chancellor criticised for lack of action on NHS
RCGP calls for longer consultations on multimorbidity burden
Cancer Researck UK links with Ideaya on PARG inhibitors
Speedy US review for MSD’s Keytruda in cervical cancer
AbbVie, Neurocrine’s fibroid drug hits PhIII targets
How Much Sleep Is Enough? Tips For Sleeping Well
How Much Sleep Is Enough? Tips For Sleeping Well